World News: 19:07 GMT Wednesday 11th July 2018. [resTORbio, Inc. via Globe Newswire via SPi World News]
BOSTON July 11 2018 GLOBE NEWSWIRE -- resTORbio NasdaqTORC today announced newly published data from a Phase 2a clinical trial demonstrating that target of rapamycin complex 1 TORC1 inhibitor treatment improved immune function and decreas ed inci...
Globe Newswire: 19:07 GMT Wednesday 11th July 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.